aprocitentan (SYH9108)
/ CSPC Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 10, 2026
A Study Evaluating Aprocitentan Tablets(SYH9108) for the Treatment of Resistant Hypertension
(clinicaltrials.gov)
- P3 | N=382 | Not yet recruiting | Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
New P3 trial • Cardiovascular • Hypertension
1 to 1
Of
1
Go to page
1